Coronavirus Investigated: Scaling vaccines
Coronavirus Investigated: Scaling vaccines
As scientists race to develop a viable coronavirus vaccine, another obstacle lurks around the bend: how to deliver that vaccine to billions of people. In a recent Policy Forum for Science, Larry Corey, virologist at Fred Hutchinson Cancer Research Center, detailed measures that could be taken to ensure effective deployment, should an effective vaccine become available. Joining Corey on the paper are authors Francis Collins, director of the National Institutes of Health; John R. Mascola, immunologist at the U.S. National Institute of Allergy and Infectious Diseases (NIAID); and NIAID director Anthony S. Fauci.Read the article: https://scim.ag/2LxZ97U
About Coronavirus Investigated
This series takes a deeper look at the concepts behind coronavirus research. Experts from several scientific disciplines answer the big questions, detailing science's response to the pandemic.
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.